Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

JRNYS vs RxPros

JRNYS
Graded #88

Higher grade

vs+2.6000000000000085
RxPros
Graded #138

Lower grade

The verdict

JRNYS takes it — 71.7/100 to 69.1/100.

JRNYS grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. JRNYS is a telehealth weight-loss program built around branded GLP-1 medications, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), dulaglutide, and liraglutide (Saxenda), paired…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJRNYS +8
78
70
Dose & formulationJRNYS +6
70
64
Clinical oversightRxPros +7
84
91
Labs & monitoringJRNYS +8
61
53
FulfillmentRxPros +9
65
74
Contract termsJRNYS +8
55
47
JRNYS · left barRxPros · right bar

The numbers

MetricJRNYSRxPros
WeighScore71.7/10069.1/100
GradeCC
Scorecard rank#88#138
Semaglutide$89/mo (plus a separate fee, brand-name)$100/mo (annual plan, compounded)
TirzepatideNot disclosed$145/mo (annual plan, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
JRNYS

Graded #88 · C

Strengths

  • Branded GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda)
  • Insured members may pay ~$25/mo for medication after deductible
  • Includes 1-on-1 coaching at every membership tier
  • Led by CMO Dr. Henry Legere with strong academic credentials
  • Transparent membership pricing ($89-$169/mo)

Where it loses points

  • Medication cost separate from membership; self-pay varies
  • Best value requires commercial insurance coverage
  • Compounded option not disclosed; brand-focused
  • State availability not published
RxPros

Graded #138 · C

Strengths

  • $99.99/month compounded semaglutide — among the cheapest in the US compounded telehealth market
  • $144.97/month compounded tirzepatide — at the lower end of the compounded tirzepatide range
  • LegitScript Certified
  • Named legal entity (RxPros LLC) with a physical Wyoming address
  • Overnight cold-packed shipping disclosed — important for GLP-1 cold-chain integrity

Where it loses points

  • Per-state availability not listed — verify your state ships before committing
  • Specific 503A pharmacy partners not named
  • Lab work not included as standard
  • LegitScript certification number not displayed (seal only)
  • Lowest headline prices ($99.99 sema / $144.97 tirz) require annual prepay; intro-first-month/quarterly tier is $134.99 sema / $224.99 tirz

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard